NPCE: Neuropace Inc
NPCE exchange rate has changed by -3.55% for today. During the day, the instrument was traded at a low of 15.68 and at a high of 16.79.
Follow Neuropace Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NPCE News
- NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy
- Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
- NPCE Explains How NeuroPace's RNS System Makes Money
- NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
- NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised
- NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript
- NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
- BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
- NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?
- NeuroPace (NPCE) Up 0.9% Since Last Earnings Report: Can It Continue?
- Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
- Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High?
- Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
- NPCE RNS System Explained: Growth Drivers and Setup for 2026
- NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
- Neuropace (NPCE) chief medical officer sells $399k in stock
- NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript
- NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
- NeuroPace beats estimates as Q4 revenue surges 24%, sending shares up 15%
- Neuropace earnings beat by $0.10, revenue topped estimates
- LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates
- Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates
Frequently Asked Questions
What is NPCE stock price today?
Neuropace Inc stock is priced at 15.74 today. It trades within 15.68 - 16.79, yesterday's close was 16.32, and trading volume reached 304. The live price chart of NPCE shows these updates.
Does Neuropace Inc stock pay dividends?
Neuropace Inc is currently valued at 15.74. Dividend policy depends on the company, while investors also watch 48.77% and USD. View the chart live to track NPCE movements.
How to buy NPCE stock?
You can buy Neuropace Inc shares at the current price of 15.74. Orders are usually placed near 15.74 or 16.04, while 304 and -3.44% show market activity. Follow NPCE updates on the live chart today.
How to invest into NPCE stock?
Investing in Neuropace Inc involves considering the yearly range 9.22 - 19.60 and current price 15.74. Many compare -4.61% and 0.96% before placing orders at 15.74 or 16.04. Explore the NPCE price chart live with daily changes.
What are Neuropace Inc stock highest prices?
The highest price of Neuropace Inc in the past year was 19.60. Within 9.22 - 19.60, the stock fluctuated notably, and comparing with 16.32 helps spot resistance levels. Track Neuropace Inc performance using the live chart.
What are Neuropace Inc stock lowest prices?
The lowest price of Neuropace Inc (NPCE) over the year was 9.22. Comparing it with the current 15.74 and 9.22 - 19.60 shows potential long-term entry points. Watch NPCE moves on the chart live for more details.
When did NPCE stock split?
Neuropace Inc has gone through stock splits historically. These changes are visible in , 16.32, and 48.77% after corporate actions.
- Previous Close
- 16.32
- Open
- 16.30
- Bid
- 15.74
- Ask
- 16.04
- Low
- 15.68
- High
- 16.79
- Volume
- 304
- Daily Change
- -3.55%
- Month Change
- -4.61%
- 6 Months Change
- 0.96%
- Year Change
- 48.77%
- Act
- Fcst
- Prev